HealthDyne Supports Employer Carve-Out Options For Obesity Treatment Access

HealthDyne, a digital pharmacy services company, announced it will participate in employer access models for FDA-approved obesity medications from Eli Lilly and Company. Under this model, HealthDyne will serve as a dispensing pharmacy for select Lilly medications in collaboration with digital health provider organizations.

The model is designed to support employer carve-out benefit options, allowing employers to offer GLP-1 and other obesity therapies with clinical oversight and defined cost structures.

HealthDyne’s platform, supported by its pharmacy network and digital health partnerships, enables access to obesity medications and supports program administration, including pricing and utilization reporting. HealthDyne . . .